The Third Circuit stated, “taken together, the statutory definition of 'device,' the treatment of off-label uses, and the guidance of the FDA all counsel in favor of scrutinizing hybrid systems ...

The Third Circuit has become the first U.S. Court of Appeals to address the application of the express preemption provision in the Medical Device Amendments of 1976 to hybrid medical devices.